In Vitro Fertilization Program Offers "Money Back Guarantee"
The Center for Reproductive Health (CRH) is now offering a service called the IntegraMed Shared Risk Refund Program. For one fee (excluding the cost of medications), women may attempt up to three fresh IVF cycles and three frozen embryo transfer cycles. If the patient doesnt take home a baby, 70 percent of the fee is returned (100 percent if donor eggs are used).
IVF is an assisted reproductive technique that involves stimulating the ovaries with fertility medications to make extra eggs. The eggs are then removed, fertilized with the partners sperm in a laboratory, and allowed to grow into embryos. One or two embryos are then transferred into the uterus.
The average person has difficulty affording just one chance at pregnancy through IVF, says Daniel Williams, MD, professor of obstetrics and gynecology and director of the IVF program, a partnership between UC and
Fees for IVF programs vary across the country, but the cost of one fresh and one frozen IVF cycle at the CRH is $7,800 (without medications). The Shared Risk Refund Program costs less than two cycles at the CRH for eligible patients.
Although the majority of patients will be successful with IVF treatment, the reality is that most patients need more than one cycle to be successful, Dr. Williams says. By offering this exclusive program to our patients, it allows them to optimize their chances to take home a baby. While patients do pay more upfront than they would with just one cycle, the refund guarantee helps reduce the financial stress of treatment.
CRH has clinical offices at
Tags
Related Stories
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.